Clinical Trial Update: A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing valganciclovir with ganciclovir for the treatment of cytomegalovirus retinitis in HIV-infected patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Retinitis
• HIV Infection

Drugs mentioned

• Cytovene (ganciclovir)
• Valcyte (valganciclovir)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Cytomegalovirus Retinitis, HIV Infections | Phase 3 | Status: COMPLETED